Further LDL cholesterol lowering through targeting PCSK9 for coronary artery disease.
- 1 December 2008
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 8 (4), 238-243
- https://doi.org/10.2174/187153008786848286